Recombinase-based reporter system and antisense technology to study gene expression and essentiality in hypoxic nonreplicating mycobacteria

FEMS Microbiology Letters

Volumn 284, Issue 1, 2008, Pages 68-75

  Rao, Srinivasa P S ^a   Camacho, Luis ^a,b   Huat Tan, Bee ^a   Boon, Calvin ^a,c   Russel, David G ^b   Dick, Thomas ^a   Pethe, Kevin ^a  

^a NOVARTIS INSTITUTE FOR TROPICAL DISEASES   (Singapore)

^b Cornell University ^*  (United States)

^c INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

Author keywords

Antisense; Hypoxic dormancy; Mycobacterium tuberculosis; Resolvase

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL DNA; COMPLEMENTARY RNA; MESSENGER RNA; RECOMBINASE; TETRACYCLINE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR DOSR;

ANIMAL CELL; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CONTROLLED STUDY; GENE EXPRESSION; GENE REPLICATION; GENETIC IDENTIFICATION; GENETIC TRAIT; HYPOXIA; MARKER GENE; MOLECULAR CLONING; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION;

ANAEROBIOSIS; ANTI-BACTERIAL AGENTS; BIOSENSING TECHNIQUES; COLONY COUNT, MICROBIAL; GENE SILENCING; GENES, REPORTER; MOLECULAR BIOLOGY; MYCOBACTERIUM TUBERCULOSIS; RECOMBINASES; RNA, ANTISENSE; TETRACYCLINE; TETRACYCLINE RESISTANCE;

CORYNEBACTERINEAE; MYCOBACTERIUM TUBERCULOSIS;

EID: 44649191637     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1111/j.1574-6968.2008.01193.x     Document Type: Article

References (30)

1. Bagchi G, Mayuri Tyagi JS (2003) Hypoxia-responsive expression of Mycobacterium tuberculosis Rv3134c and devR promoters in Mycobacterium smegmatis. Microbiology 149 : 2303 2305.
2. Bardarov S, Bardarov S Jr., Pavelka MS Jr. et al 2002) Specialized transduction: an efficient method for generating marked and unmarked targeted gene disruptions in Mycobacterium tuberculosis, M. bovis BCG and M. smegmatis. Microbiology 148 : 3007 3017.
3. Belisle JT Sonnenberg MG (1998) Isolation of genomic DNA from mycobacteria. Methods Mol Biol 101 : 31 44.
4. Betts JC, Lukey PT, Robb LC, McAdam RA Duncan K (2002) Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol Microbiol 43 : 717 731.
5. Blokpoel MC, Murphy HN, O'Toole R et al 2005) Tetracycline-inducible gene regulation in mycobacteria. Nucleic Acids Res 33 : e22.
6. Boon C Dick T (2002) Mycobacterium bovis BCG response regulator essential for hypoxic dormancy. J Bacteriol 184 : 6760 6767.
7. Boon C, Li R, Qi R Dick T (2001) Proteins of Mycobacterium bovis BCG induced in the Wayne dormancy model. J Bacteriol 183 : 2672 2676.
8. Boshoff HIM Barry CE (2005) Tuberculosis: metabolism and respiration in the absence of growth. Nat Rev Microbiol 3 : 70 80.
9. Camilli A, Beattie DT Mekalanos JJ (1994) Use of genetic recombination as a reporter of gene expression. Proc Natl Acad Sci USA 91 : 2634 2638.
10. Carroll P, Muttucumaru DG Parish T (2005) Use of a tetracycline-inducible system for conditional expression in Mycobacterium tuberculosis and Mycobacterium smegmatis. Appl Environ Microbiol 71 : 3077 3084.
11. Dick T (2001) Dormant tubercle bacill: the key to more effective TB chemotherapy? J Antimicrob Chemother 47 : 117 118.
12. Ehrt S, Guo XV, Hickey CM, Ryou M, Monteleone M, Riley LW Schnappinger D (2005) Controlling gene expression in mycobacteria with anhydrotetracycline and Tet repressor. Nucleic Acids Res 33 : e21.
13. Gandotra S, Schnappinger D, Monteleone M, Hillen W Ehrt S (2007) In vivo gene silencing identifies the Mycobacterium tuberculosis proteasome as essential for the bacteria to persist in mice. Nat Med 13 : 1515 1520.
14. Hutter B Dick T (2000) Analysis of the dormancy-inducible narK2 promoter in Mycobacterium bovis BCG. FEMS Microbiol Lett 188 : 141 146.
15. Kong D Kunimoto DY (1995) Secretion of human interleukin 2 by recombinant Mycobacterium bovis BCG. Infect Immun 63 : 799 803.
16. Lim A, Eleuterio M, Hutter B, Murugasu-Oei B Dick T (1999) Oxygen depletion-induced dormancy in Mycobacterium bovis BCG. J Bacteriol 181 : 2252 2256.
17. Malaga W, Perez E Guilhot C (2003) Production of unmarked mutations in mycobacteria using site-specific recombination. FEMS Microbiol Lett 219 : 261 268.
18. Muttucumaru DG, Roberts G, Hinds J, Stabler RA Parish T (2004) Gene expression profile of Mycobacterium tuberculosis in a non-replicating state. Tuberculosis (Edinburg) 84 : 239 246.
19. Parish T Stoker NG (1997) Development and use of a conditional antisense mutagenesis system in mycobacteria. FEMS Microbiol Lett 154 : 151 157.
20. Park HD, Guinn KM, Harrell MI et al 2003) Rv3133c/dosR is a transcription factor that mediates the hypoxic response of Mycobacterium tuberculosis. Mol Microbiol 48 : 833 843.
21. Rustad TR, Harrell MI, Liao R Sherman DR (2008) The enduring hypoxic response of Mycobacterium tuberculosis. PLoS ONE 3 : e1502.
22. Saviola B, Woolwine SC Bishai WR (2003) Isolation of acid-inducible genes of Mycobacterium tuberculosis with the use of recombinase-based in vivo expression technology. Infect Immun 71 : 1379 1388.
23. Sherman DR, Voskuil M, Schnappinger D, Liao R, Harrell MI Schoolnik GK (2001) Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding alpha-crystallin. Proc Natl Acad Sci USA 98 : 7534 7539.
24. Spigelman MK (2007) New tuberculosis therapeutics: a growing pipeline. J Infect Dis 196 : (suppl 1) : S28 S34.
25. Timm J, Lim EM Gicquel B (1994) Escherichia coli-mycobacteria shuttle vectors for operon and gene fusions to lacZ: the pJEM series. J Bacteriol 176 : 6749 6753.
26. Wayne LG Hayes LG (1996) An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence. Infect Immun 64 : 2062 2069.
27. Wayne LG Sohaskey CD (2001) Nonreplicating persistence of Mycobacterium tuberculosis. Annual Rev Microbiol 55 : 139 163.
28. Wayne LG Sramek HA (1994) Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis. Antimicrob Agents Chemother 38 : 2054 2058.
29. WHO (2006) Global Tuberculosis Control: Surveillance, Planning, Financing, World Health Organization, Geneva.
30. Wu S, Howard ST, Lakey DL et al 2004) The principal sigma factor sigA mediates enhanced growth of Mycobacterium tuberculosis in vivo. Mol Microbiol 51 : 1551 1562.